DE68921063D1 - Verfahren zur Herstellung von menschlichem Serumalbumin durch Gärung eines genetisch veränderten Mikroorganismus in Gegenwart eines Polyalkylens. - Google Patents

Verfahren zur Herstellung von menschlichem Serumalbumin durch Gärung eines genetisch veränderten Mikroorganismus in Gegenwart eines Polyalkylens.

Info

Publication number
DE68921063D1
DE68921063D1 DE68921063T DE68921063T DE68921063D1 DE 68921063 D1 DE68921063 D1 DE 68921063D1 DE 68921063 T DE68921063 T DE 68921063T DE 68921063 T DE68921063 T DE 68921063T DE 68921063 D1 DE68921063 D1 DE 68921063D1
Authority
DE
Germany
Prior art keywords
fermentation
serum albumin
human serum
polyalkylene
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68921063T
Other languages
English (en)
Other versions
DE68921063T2 (de
Inventor
Peter Clarke
Stephen Collins
David Mead
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Albumedix Ltd
Original Assignee
Delta Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10643175&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE68921063(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Delta Biotechnology Ltd filed Critical Delta Biotechnology Ltd
Publication of DE68921063D1 publication Critical patent/DE68921063D1/de
Application granted granted Critical
Publication of DE68921063T2 publication Critical patent/DE68921063T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
DE68921063T 1988-09-07 1989-09-06 Verfahren zur Herstellung von menschlichem Serumalbumin durch Gärung eines genetisch veränderten Mikroorganismus in Gegenwart eines Polyalkylens. Expired - Fee Related DE68921063T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888820951A GB8820951D0 (en) 1988-09-07 1988-09-07 Fermentation method
PCT/GB1989/001046 WO1990002808A2 (en) 1988-09-07 1989-09-06 Fermentation of genetically engineered yeast in the presence of a polyalkylene compound

Publications (2)

Publication Number Publication Date
DE68921063D1 true DE68921063D1 (de) 1995-03-23
DE68921063T2 DE68921063T2 (de) 1995-07-06

Family

ID=10643175

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68921063T Expired - Fee Related DE68921063T2 (de) 1988-09-07 1989-09-06 Verfahren zur Herstellung von menschlichem Serumalbumin durch Gärung eines genetisch veränderten Mikroorganismus in Gegenwart eines Polyalkylens.

Country Status (14)

Country Link
EP (1) EP0386222B1 (de)
JP (1) JP2996405B2 (de)
KR (1) KR900702001A (de)
AT (1) ATE118249T1 (de)
AU (1) AU618413B2 (de)
CA (1) CA1336416C (de)
DE (1) DE68921063T2 (de)
DK (1) DK107490D0 (de)
FI (1) FI96040C (de)
GB (1) GB8820951D0 (de)
HU (1) HU207350B (de)
IE (1) IE61268B1 (de)
WO (1) WO1990002808A2 (de)
ZA (1) ZA896847B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0404317A3 (de) * 1989-06-22 1991-10-02 Petrolite Corporation Verwendung von äthoxylierten, propoxylierten Alkoholen zur Schaumverhinderung oder -verminderung in Fermentationsbrühe
JPH0671432B2 (ja) * 1991-03-20 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
WO1996033861A1 (de) * 1995-04-27 1996-10-31 Sucher & Holzer Bauplanungs- Und Handelsgesellschaft Mbh Schneckenpresse
EP1004673B1 (de) * 1997-04-03 2005-12-07 Mitsubishi Pharma Corporation Verfahren zur herstellung von fremden proteinen
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
AU2007278994B2 (en) 2006-07-24 2013-08-15 Biorexis Pharmaceutical Corporation Exendin fusion proteins
JP7050528B2 (ja) * 2017-03-01 2022-04-08 三洋化成工業株式会社 有用物質の生産方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2417410C2 (de) * 1973-04-11 1983-02-24 Cincinnati Milacron-Heald Corp., 01606 Worcester, Mass. Schleifmaschine zum Bearbeiten von hohlzylindrischenWerkstücken mit von der Kreisform abweichendem Querschnitt
DE2917535C2 (de) * 1979-04-30 1986-10-30 Hoechst Ag, 6230 Frankfurt Gegen Denaturierung beständige Insulinlösungen
IL66614A (en) * 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
GB8613388D0 (en) * 1986-06-03 1986-07-09 Delta Biotechnology Ltd Induction of galactose regulated gene expression in yeast
EP0262516A2 (de) * 1986-09-29 1988-04-06 Miles Inc. Genetische Transformation von Milchsäurebakterien

Also Published As

Publication number Publication date
FI96040B (fi) 1996-01-15
DK107490A (da) 1990-05-01
CA1336416C (en) 1995-07-25
ZA896847B (en) 1990-07-25
GB8820951D0 (en) 1988-10-05
IE892864L (en) 1990-03-07
DK107490D0 (da) 1990-05-01
WO1990002808A2 (en) 1990-03-22
JPH03500969A (ja) 1991-03-07
FI902259A0 (fi) 1990-05-04
JP2996405B2 (ja) 1999-12-27
FI96040C (fi) 1996-04-25
HU207350B (en) 1993-03-29
AU4310789A (en) 1990-04-02
ATE118249T1 (de) 1995-02-15
EP0386222B1 (de) 1995-02-08
DE68921063T2 (de) 1995-07-06
AU618413B2 (en) 1991-12-19
IE61268B1 (en) 1994-10-19
KR900702001A (ko) 1990-12-05
EP0386222A1 (de) 1990-09-12
WO1990002808A3 (en) 1990-04-19
HU895572D0 (en) 1991-07-29
HUT56398A (en) 1991-08-28

Similar Documents

Publication Publication Date Title
DE68929115T2 (de) Verfahren zur Herstellung von menschlichem Serumalbumin in Hefe
IT8621106A0 (it) Vettore ad espressione e secrezione in lieviti, utile per lapreparazione di proteine eterologhe.
DE68921063T2 (de) Verfahren zur Herstellung von menschlichem Serumalbumin durch Gärung eines genetisch veränderten Mikroorganismus in Gegenwart eines Polyalkylens.
DE3788229T2 (de) Verfahren zur isolierung von ca 125-antigen.
DE69427955T2 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
DE69023648D1 (de) Herstellung eines virus und reinigung von virenüberzugsproteinen zur impfstoffverwendung.
ATE144238T1 (de) Verwendung von pilzmyzel als bodenhilfsstoff
DE69103779T2 (de) Verfahren zur Herstellung von tert. Butylalkohol.
DE69018755T2 (de) Verfahren zur Herstellung von 3-(L-Pyroglutamyl)-L-thiazolidin-4-carbonsäure-Derivaten.
ATE271078T1 (de) Copolymere mit amphiphilen untereinheiten, verfahren zu deren herstellung und deren verwendung
EP0298756A3 (de) Optisch aktive Allylalkohol und Verfahren zur Herstellung von Leucotrien-B4, das sie verwendet
DE3888887D1 (de) Monoklonale Antikörper gegen E7-Protein des Humanen Papillomvirus Typ 16, Verfahren zu ihrer Herstellung sowie ihre Verwendung.
DE69715733T2 (de) Verfahren zur Herstellung von 5-Brom-2-Fluorbenzolboronsäure
ATE104310T1 (de) Verfahren zur herstellung von isepamicin.
DE3764492D1 (de) Verfahren zur herstellung von als adjuvans fuer detergentien verwendbaren oxodisuccinaten.
ATE129284T1 (de) Attenuiertes hundeparvovirus (cpv), cpv enthaltender impfstoff und verfahren zur verhütung von infektionen durch cpv bei hunden.
DE69019843T2 (de) Verfahren zur Herstellung von NADH-Oxydase.
DE59106074D1 (de) Verfahren zur Herstellung von Copolymerisaten aus Maleinsäuremonoalkylestern oder Maleinsäure und deren Salzen und Vinylalkylethern.
DE69013187D1 (de) Verfahren zur Herstellung von Alkylenglykolmonosorbaten.
DE59103279D1 (de) Verfahren zur Herstellung von optisch aktiven aliphatischen Hydroxycarbonsäureestern.
DE59006944D1 (de) Verfahren zur Herstellung von 2-Mercapto-4-methyl-1,3-thiazol-5-yl-essigsäure und deren Ester.
DE59309506D1 (de) Verfahren zur Herstellung von Aldehyden
DE69116198T2 (de) Verfahren zur Herstellung von D-Isocitronensäure durch Fermentation
DE3668166D1 (de) Verfahren zur herstellung von alkylarylethern.
DE59108700D1 (de) Verfahren zur herstellung von 17-oxosteroiden

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: NOVOZYMES DELTA LTD., NOTTINGHAM, GB

8339 Ceased/non-payment of the annual fee